Lawson, D H <br/><br/>
European postmarketing surveillance of ramipril in hypertension. 1. Feasibility and study cohort.  [electronic resource] 

 -  European journal of clinical pharmacology  1995 
 - 73-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/BF00192362  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiotensin-Converting Enzyme Inhibitors--adverse effects<br/>Belgium<br/>Cohort Studies<br/>Feasibility Studies<br/>Female<br/>Germany<br/>Humans<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Product Surveillance, Postmarketing<br/>Prospective Studies<br/>Ramipril--adverse effects<br/>United Kingdom